NCT00170274

APART: Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias

Prevention and Automatic Therapy of Atrial Arrhythmias in Patients With Paroxysmal Supraventricular Tachycardias Who Need Cardiac Pacing

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 156 (actual)
• Sponsor: Medtronic Cardiac Rhythm and Heart Failure · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of APART is the assessment of the therapeutic and preventive stimulation algorithms of the Medtronic AT500 and following devices in patients with atrial tachyarrhythmias and an indication for cardiac pacing according to the German guidelines. Medication is controlled throughout the study with a beta-blocker as the only antiarrhythmic drug.

Conditions

• Tachyarrhythmia

Interventions

Type	Name	Description
DEVICE	Activation of preventive and therapeutic algorithms for treatment of AF	Algorithms in At 500 or Enrhyhtm for prevention and termination of Atrial Fibrillation
DEVICE	AF Prevention and Therapy Algorithms On	Activation of AF-prevention and termination algorithms in AT 500 or EnRhyhtm

Timeline

• Start date: 2000-08-01
• Primary completion: 2011-06-01
• Completion: 2014-10-01
• First posted: 2005-09-15
• Last updated: 2025-07-03

Locations

6 sites across 1 country: Germany